Session 1: $299

Investment Types Along
the Capital Stack & 
Due Diligence

By session end, you will understand:

  • The different types of investment from seed to institutional
  • Risk-reward at each level of investing
  • Essential categories of due diligence of any venture, including
    intellectual property, barriers to entry, and
    competitive advantage

Course 1 Registration - 30 day access

  • Price: $299.00
    Refund Policy: 100% within 24 hours of purchase. 50% within 48 hours of purchase. No refunds thereafter. Limitation of Liability: This online course does not endorse or make any representations or warranties concerning companies presented. All lesson contents are for educational purposes only. The organizers disclaim any liability for investment losses or damages flowing from Participant’s individual investment decisions. Participants should obtain independent legal and financial advice prior to making any investment decision. All Participants understand that they will hold harmless the course organizers, instructors, sponsors and ECF Biosolutions for any investment decision outcomes. They course organizers, instructors, sponsors and ECF Biosolutions do not constitute a venture fund, investment bank, broker/dealer, investment clearinghouse, or any other form of investment advisor or otherwise, and are not registered with the Securities and Exchange Commission or any state securities commission. They do not provide advice, recommendations, or any other indications of appropriateness or inappropriateness for a particular investment. Confidentiality of Material: All educational content is being furnished on a confidential basis. By accepting the material, the registrant agrees to keep confidential the information contained herein. Any unauthorized use, distribution, or reproduction of the material is prohibited. All sales are final.
  • American Express
  • $0.00


Elizabeth Cho-Fertikh, PhD

  • Founder, ECF Biosolutions
  • Partner, 1812 Ventures

Angel investor & venture capital partner. 20 years cancer research, high impact scientific journal publications, biotech R&D, regulatory and management experience for dozens of start-ups and industry, including MacroGenics, Gore Medical, Beckman Coulter, Amgen.  BA, Johns Hopkins, PhD, Thomas Jefferson University, Postdoctoral Training, Harvard Medical School.


Fred Gumbinner, JD

  • Managing Partner, G2 GEM Finance
  • General Partner, SaaS Venture Fund
  • President, Keiretsu Forum, DC Chapter

Serial executive, entrepreneur, advisor, mentor, investor. Participation in $35 billion+ in successful financing & corporate transactions. Capital raising from seed to institutional. BA, Colgate University (magna cum laude) and JD, The University of Michigan Law School (magna cum laude and Contributing Editor of the Michigan Law Review)